BIO-91202

N/A

Report date: 2025/01/26 18:39:01

Base Information

Drug NameBIO-91202
Drug Alias NameMARCKS inhibitor peptide (BioMarck Pharmaceuticals)BIO-91202
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMyristoylated alanine-rich C-kinase substrate inhibitors
TargetsMyristoylated alanine-rich C-kinase substrate
Therapy Area/IndicationsUveitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNorth Carolina State University
China Registration ClassN/A

Develop Information

Active CompaniesBiomarck Pharmaceuticals LtdNorth Carolina State University
Inactive CompaniesN/A
Active IndicationsUveitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A